Variant report
Variant | esv3692775 |
---|---|
Chromosome Location | chr3:22081161-22092207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:22090916..22093719-chr3:22096309..22098471,5 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7623423 | chr3:22081161-22081162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs535776198 | chr3:22081209-22081210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548710861 | chr3:22081215-22081216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs57229805 | chr3:22081222-22081223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183995035 | chr3:22081261-22081262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74392675 | chr3:22081263-22081264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571187397 | chr3:22081269-22081270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534568894 | chr3:22081270-22081271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555692005 | chr3:22081284-22081285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568113392 | chr3:22081297-22081298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376229974 | chr3:22081304-22081305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548580495 | chr3:22081308-22081309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568942536 | chr3:22081327-22081328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539646212 | chr3:22081328-22081329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557602284 | chr3:22081346-22081347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7623592 | chr3:22081367-22081368 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs369660086 | chr3:22081382-22081383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116257025 | chr3:22081439-22081440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146539908 | chr3:22081448-22081449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117135606 | chr3:22081467-22081468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141249813 | chr3:22081483-22081484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145001765 | chr3:22081497-22081498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530986413 | chr3:22081504-22081505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76552322 | chr3:22081509-22081510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376432118 | chr3:22081514-22081515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138853465 | chr3:22081528-22081529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547362162 | chr3:22081547-22081548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148956605 | chr3:22081548-22081549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190245155 | chr3:22081560-22081561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577093841 | chr3:22081661-22081662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550383648 | chr3:22081671-22081672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568956070 | chr3:22081682-22081683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116829650 | chr3:22081686-22081687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs174103 | chr3:22081699-22081700 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs181533525 | chr3:22081721-22081722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116178015 | chr3:22081726-22081727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553299828 | chr3:22081728-22081729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7616274 | chr3:22081770-22081771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111351022 | chr3:22081782-22081783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13433827 | chr3:22081791-22081792 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148515572 | chr3:22087409-22087410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75112654 | chr3:22087414-22087415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565519792 | chr3:22087420-22087421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543533443 | chr3:22087444-22087445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187738281 | chr3:22087449-22087450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536267224 | chr3:22087462-22087463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs259462 | chr3:22087474-22087475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs7632328 | chr3:22087497-22087498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373178299 | chr3:22087513-22087514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34362610 | chr3:22087533-22087534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22079800-22081800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:22087400-22087800 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr3:22087400-22087800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr3:22087400-22088200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr3:22088000-22088200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr3:22089400-22089600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |